These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37595956)

  • 21. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between pharmacist-led telehealth services and improvements in cardiovascular outcomes among patients with cardiovascular risk factors: A scoping review.
    Nkemdirim Okere A; Balogun A; Smith A; Stevens J
    Int J Cardiol Cardiovasc Risk Prev; 2023 Dec; 19():200206. PubMed ID: 37663032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Financial performance and reimbursement of pharmacist-led chronic care management.
    Martin R; Tram K; Le L; Simmons C
    Am J Health Syst Pharm; 2020 Nov; 77(23):1973-1979. PubMed ID: 32995845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.
    Sherrill CH; Houpt CT; Dixon EM; Richter SJ
    J Manag Care Spec Pharm; 2020 May; 26(5):600-609. PubMed ID: 32347180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
    Smith AM; Hamann GL; Campbell JD; Sprabery LR
    J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation and Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided Medication Therapy Management Program.
    Theising KM; Fritschle TL; Scholfield AM; Hicks EL; Schymik ML
    Pharmacotherapy; 2015 Nov; 35(11):e159-63. PubMed ID: 26598100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis.
    Andrick B; Tusing L; Jones LK; Hu Y; Sneidman R; Gregor C; Basu S; Lynch JP; Vadakara J
    Transplant Cell Ther; 2022 Jun; 28(6):334.e1-334.e9. PubMed ID: 35189400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effectiveness and cost savings in diabetes care, supported by pharmacist counselling.
    Rodriguez de Bittner M; Chirikov VV; Breunig IM; Zaghab RW; Shaya FT
    J Am Pharm Assoc (2003); 2017; 57(1):102-108.e4. PubMed ID: 27769877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus.
    McFarland M; Davis K; Wallace J; Wan J; Cassidy R; Morgan T; Venugopal D
    Pharmacotherapy; 2012 May; 32(5):420-6. PubMed ID: 22488512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of Outpatient Pharmacist-led Hypertension Management for Under-Resourced Patients: A Pilot Study.
    Stewart B; Brody A; Garwood CL; Zhang L; Levy PD
    Innov Pharm; 2021; 12(2):. PubMed ID: 34345511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring barriers and facilitators to pharmacist-provided diabetes self-management education and support.
    Gawlik G; Nguyen E; Robinson R
    J Am Pharm Assoc (2003); 2023; 63(1):74-79. PubMed ID: 36114100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program.
    Frederick A; Juan J; Ivy D; Maldonado YM
    J Pharm Pract; 2022 Feb; 35(1):70-74. PubMed ID: 32830604
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.